Literature DB >> 7695193

Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions.

Z S Galis1, M Muszynski, G K Sukhova, E Simon-Morrissey, P Libby.   

Abstract

Dysregulated extracellular matrix (ECM) metabolism may contribute to vascular remodeling during atherogenesis. The ability of vascular cells to synthesize the components of ECM is well characterized, but less is known about their capacity to degrade ECM and the factors that may regulate this process. We therefore studied the expression of matrix metalloproteinases (MMPs), enzymes that degrade various components of ECM, and of tissue inhibitors of MMPs (TIMPs) by untreated or cytokine-stimulated human smooth muscle cells (SMC). Messenger RNA was studied by Northern blotting, and proteins secreted in culture by SMC were identified by immunoprecipitation. Gelatinolytic and caseinolytic activity of MMPs was detected zymographically. SMC constitutively produced a 72 kDa type IV gelatinase (GL), TIMP-1, and TIMP-2. Upon stimulation with IL1 or TNF alpha, SMC synthesized in addition 92 kDa GL, stromelysin, and interstitial collagenase, MMPs that together can degrade all of the ECM components. IL1 or TNF alpha did not alter the level of TIMP mRNA and protein, suggesting that a net excess of MMP production under these conditions may promote breakdown of the vascular ECM. To test the in vivo relevance of these in vitro findings, we analyzed immunohistochemically normal human arteries and carotid atheromas. Normal tissue and the medial layer underlying lesions stained uniformly for 72 kDa GL and TIMPs 1 and 2. Lesions showed regionally increased MMP expression: the shoulders of atherosclerotic plaques contained stromelysin and 92 kDa GL associated with SMC, and clusters of macrophage-derived foam cells associated with the lipid core stained intensely for all MMPs studied. Endothelial cells covering atheroma or of the plaque microvasculature contained interstitial collagenase. In pathological conditions associated with local release of cytokines in the vessel wall, enhanced regional expression of vascular MMPs may contribute to SMC migration and weakening of matrix that would favor plaque rupture, events associated with the development or complication of the atherosclerotic lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7695193     DOI: 10.1111/j.1749-6632.1994.tb17348.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  42 in total

1.  Macrophage metalloproteinases degrade high-density-lipoprotein-associated apolipoprotein A-I at both the N- and C-termini.

Authors:  Ivano Eberini; Laura Calabresi; Robin Wait; Gabriella Tedeschi; Angela Pirillo; Lina Puglisi; Cesare R Sirtori; Elisabetta Gianazza
Journal:  Biochem J       Date:  2002-03-15       Impact factor: 3.857

Review 2.  Extra-cellular matrix in vascular networks.

Authors:  George Bou-Gharios; Markella Ponticos; Vineeth Rajkumar; David Abraham
Journal:  Cell Prolif       Date:  2004-06       Impact factor: 6.831

3.  Meta-analysis of C242T polymorphism in CYBA genes: risk of acute coronary syndrome is lower in Asians but not in Caucasians.

Authors:  Po Hu; Ming-yuan Huang; Xin-yang Hu; Xiao-jie Xie; Mei-xiang Xiang; Xian-bao Liu; Jian-an Wang
Journal:  J Zhejiang Univ Sci B       Date:  2015-05       Impact factor: 3.066

4.  Relation of baseline plasma MMP-1 levels to long-term all-cause mortality in patients with known or suspected coronary artery disease referred for coronary angiography.

Authors:  Erdal Cavusoglu; Jonathan D Marmur; Sudhanva Hegde; Sunitha Yanamadala; Olcay A Batuman; Vineet Chopra; Gonca Ay; Calvin Eng
Journal:  Atherosclerosis       Date:  2015-01-14       Impact factor: 5.162

5.  Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release.

Authors:  D J Brull; J Sanders; A Rumley; G D Lowe; S E Humphries; H E Montgomery
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

6.  Association between matrix metalloproteinase family gene polymorphisms and ischemic stroke: a meta-analysis.

Authors:  Dan Wen; Xin Du; Shao-Ping Nie; Jian-Zeng Dong; Chang-Sheng Ma
Journal:  Mol Neurobiol       Date:  2014-04-26       Impact factor: 5.590

Review 7.  Age-related changes affecting atherosclerotic risk. Potential for pharmacological intervention.

Authors:  L G Spagnoli; A Mauriello; A Orlandi; G Sangiorgi; E Bonanno
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

8.  Cystatin C deficiency in human atherosclerosis and aortic aneurysms.

Authors:  G P Shi; G K Sukhova; A Grubb; A Ducharme; L H Rhode; R T Lee; P M Ridker; P Libby; H A Chapman
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

9.  Regulations of the key mediators in inflammation and atherosclerosis by aspirin in human macrophages.

Authors:  Li Lu; Hong Liu; Jiahe Peng; Lin Gan; Lili Shen; Qian Zhang; Liangpeng Li; Li Zhang; Chang Su; Yu Jiang
Journal:  Lipids Health Dis       Date:  2010-02-06       Impact factor: 3.876

10.  Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching.

Authors:  Chad Johnson; Hak-Joon Sung; Susan M Lessner; M Elizabeth Fini; Zorina S Galis
Journal:  Circ Res       Date:  2003-12-11       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.